Bhutan vs Sur: Previously treated cases tested for RR-/MDR-TB
Bhutan
100.0%
in 2024
Sur
62.0%
in 2024
Bhutan rank
1st
Sur rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Bhutan
- Sur
How they compare
Bhutan currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Bhutan's figure about 1.6 times Sur's.
The two have swapped places 10 times across 17 shared years of data; in 2005 it was Bhutan ahead.
Bhutan ranks 1st and Sur ranks 1st of 180 countries.
Across the 3 decades both report, Bhutan averaged higher in 1 and Sur in 2.
Head to head by decade
| Decade | Bhutan | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.6% | 14.3% | 8.7% | Sur |
| 2010s | 49.7% | 53.0% | 3.3% | Sur |
| 2020s | 95.2% | 78.4% | 16.8% | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Bhutan or Sur?
- Bhutan, at 100.0% against 62.0% in Sur as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Bhutan and Sur?
- 38.0%, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Sur?
- 17 years are reported by both, from 2005 to 2024.
- How do Bhutan and Sur rank globally for previously treated cases tested for rr-/mdr-tb?
- Bhutan ranks 1st and Sur ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.